MARAFIOTI, TERESA
MARAFIOTI, TERESA
Tumoral immune-infiltrate (IF), PD-L1 expression and role of CD8/TIA-1 lymphocytes in localized osteosarcoma patients treated within protocol ISG-OS1
2017 Palmerini, Emanuela; Agostinelli, Claudio; Picci, Piero; Pileri, Stefano; Marafioti, Teresa; Lollini, Pier-Luigi; Scotlandi, Katia; Longhi, Alessandra; Benassi, Maria Serena; Ferrari, Stefano
Nodal reactive and neoplastic proliferation of monocytoid and marginal zone B cells: an immunoarchitectural and molecular study highlighting the relevance of IRTA1 and T-bet as positive markers.
2013 Bob R;Falini B;Marafioti T;Paterson JC;Pileri S;Stein H
Induction of p53 and up-regulation of the p53 pathway in the human 5q- syndrome.
2010 Pellagatti A; Marafioti T; Paterson JC; Barlow JL; Drynan LF; Giagounidis A; Pileri SA; Cazzola M; McKenzie AN; Wainscoat JS; Boultwood J.
The inducible T-cell co-stimulator molecule is expressed on subsets of T cells and is a new marker of lymphomas of T follicular helper cell-derivation.
2010 Marafioti T; Paterson JC; Ballabio E; Chott A; Natkunam Y; Rodriguez-Justo M; Plonquet A; Rodriguez-Pinilla SM; Klapper W; Hansmann ML; Pileri SA; Isaacson PG; Stein H; Piris MA; Mason DY; Gaulard P.
Novel markers of normal and neoplastic human plasmacytoid dendritic cells.
2008 Marafioti T; Paterson JC; Ballabio E; Reichard KK; Tedoldi S; Hollowood K;Dictor M; Hansmann ML; Pileri SA; Dyer MJ; Sozzani S; Dikic I; Shaw AS; Petrella T; Stein H; Isaacson PG; Facchetti F; Mason DY.
Aberrant somatic hypermutation in tumor cells of nodular-lymphocyte-predominant and classic Hodgkin lymphoma.
2006 Liso A; Capello D; Marafioti T; Tiacci E; Cerri M; Distler V; Paulli M; Carbone A; Delsol G; Campo E; Pileri S; Pasqualucci L; Gaidano G; Falini B.
Cancer-associated carbohydrate identification in Hodgkin's lymphoma by carbohydrate array profiling.
2006 Lawrie CH; Marafioti T; Hatton CS; Dirnhofer S; Roncador G; Went P; Tzankov A; Pileri SA; Pulford K; Banham AH.
Jaw1/LRMP, a germinal centre-associated marker for the immunohistological study of B-cell lymphomas
2006 Tedoldi S; Paterson JC; Cordell J; Tan SY; Jones M; Manek S; Dei Tos AP; Roberton H; Masir N; Natkunam Y; Pileri SA; Facchetti F; Hansmann ML; Mason DY; Marafioti T.
The differential expression of LCK and BAFF-receptor and their role in apoptosis in human lymphomas.
2006 Paterson JC; Tedoldi S; Craxton A; Jones M; Hansmann ML; Collins G; Roberton H; Natkunam Y; Pileri S; Campo E; Clark EA; Mason DY; Marafioti T.
Expression pattern of intracellular leukocyte-associated proteins in primary mediastinal B cell lymphoma.
2005 Marafioti T; Pozzobon M; Hansmann ML; Gaulard P; Barth TF; Copie-Bergman C; Roberton H; Ventura R; Martin-Subero JI; Gascoyne RD; Pileri SA; Siebert R; Hsi ED; Natkunam Y; Moller P; Mason DY.
The NFATc1 transcription factor is widely expressed in white cells and translocates from the cytoplasm to the nucleus in a subset of human lymphomas.
2005 Marafioti T; Pozzobon M; Hansmann ML; Ventura R; Pileri SA; Roberton H; Gesk S; Gaulard P; Barth TF; Du MQ; Leoncini L; Moller P; Natkunam Y; Siebert R; Mason DY.
BCL-6 gene shows a characteristic mutation pattern in primary mediastinal B cell lymphoma.
2004 Marafioti T.; Pileri S.A.
Expression of intracellular signaling molecules in classical and lymphocyte predominance Hodgkin’s disease.
2004 MARAFIOTI T.; PIZZOBON M.; HANSMANN M.L.; DELSOL G.; PILERI S.A.; MASON D.Y.
Histopathology of B-cell chronic lymphocytic leukemia.
2004 PILERI SA; SABATTINI E; AGOSTINELLI C; BODEGA L; ROSSI M; ZINZANI P.; MARAFIOTI T.
Leukocyte-specific phosphoprotein-1 and PU.1: two useful markers for distinguishing T-cell-rich B-cell lymphoma from lymphocyte-predominant Hodgkin’s disease.
2004 Marafioti T.; Mancini C.; Ascani S.; Sabattini E.; Zinzani P.L.; Pozzobon M.; Pulford K.; Falini B.; Jaffe E.S.; Müller-Hermelink H.K.; Mason D.Y.; Pileri S.A.